Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. NIEDERSAECHSISCHE BOERSE ZU HANNOVER
  5. Cannovum AG
  6. News
  7. Summary
    27N   DE000A2LQU21

CANNOVUM AG

(27N)
SummaryChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

PRESS RELEASE: Cannovum AG enters supply agreement for medical cannabis with Aurora Europe

06/24/2021 | 03:08am EDT
DGAP-News: Cannovum AG / Key word(s): Product Launch 
Cannovum AG enters supply agreement for medical cannabis with Aurora Europe 
2021-06-24 / 09:06 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Cannovum AG (stock exchanges Düsseldorf, Munich, Hamburg, Berlin, gettex: ISIN DE000A2LQU21) has entered into a long 
term supply agreement with Aurora through its licensed subsidiary, Cannovum Health eG. Starting today, Cannovum will 
distribute the full range of medical cannabis products offered by Aurora to pharmacies throughout Germany. 
The canadian company Aurora is one of the largest authorised manufacturers of medical cannabis in the European Union. 
After the German legalization of medical cannabis in 2017 Aurora joined the German market with their acquisition of the 
German company Pedanios, thus making Aurora / Pedanios products one of the first cannabis medicines available in 
Germany. This allowed doctors and pharmacists to gain experience in treating their patients with these products. 
Expanding the medical cannabis portfolio with the full range of Aurora products is therefore an important step for 
Cannovum towards ensuring best possible patient care. 
"We want to support doctors and pharmacists in finding the appropriate treatment for their patients. In order for us to 
achieve that, we need to provide a full portfolio of medical cannabis which gives them the opportunity to fully 
customize the therapy. By partnering with Aurora we are confident that we continue to provide high quality medication 
to ensure every patient receives the best therapy", says Pia Marten, CEO of Cannovum AG. 
Cannovum's own team of pharmaceutical representatives has received intensive training in the new products, in order to 
confidently advise pharmacists and doctors. 
Contact: 
Linda Rasch, IR & PR, Cannovum AG 
Phone +49 30 3982 163 62, linda.rasch@cannovum.com 
Cannovum AG is the first German listed medical cannabis company. Through its subsidiary Cannovum Health eG, Cannovum is 
a fully licensed pharmaceutical wholesaler, importer and manufacturer of high-quality medical cannabis products based 
in Berlin. The company focuses on the import of high-quality cannabinoid products, medical-scientific education and 
all-encompassing distribution for simplified and facilitated access to cannabis-based therapies. 
For more information, visit www.cannovum.com 
=---------------------------------------------------------------------------------------------------------------------- 
2021-06-24 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Cannovum AG 
              Rheinsberger Str. 76/77 
              10115 Berlin 
              Germany 
Phone:        +49 (0)30 3982 16360 
E-mail:       ir@cannovum.com 
Internet:     www.cannovum.com 
ISIN:         DE000A2LQU21 
WKN:          A2LQU2 
Listed:       Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich 
EQS News ID:  1211413 
 
End of News   DGAP News Service 
=------------ 

1211413 2021-06-24

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1211413&application_name=news 
 

(END) Dow Jones Newswires

June 24, 2021 03:07 ET (07:07 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
AURORA CANNABIS INC. -3.08% 7.55 Delayed Quote.-26.51%
AUXLY CANNABIS GROUP INC. -3.92% 0.245 Delayed Quote.-3.92%
CANNOVUM AG 0.00% 4.8 End-of-day quote.0.00%
CANOPY GROWTH CORPORATION -4.45% 17.61 Delayed Quote.-43.77%
CRONOS GROUP INC. -5.13% 7.21 Delayed Quote.-18.44%
DJ INDUSTRIAL 0.10% 34798 Delayed Quote.13.59%
HEXO CORP. -1.63% 2.42 End-of-day quote.-34.69%
ORGANIGRAM HOLDINGS INC. -4.09% 3.05 Delayed Quote.80.47%
SUPREME CANNABIS 1.52% 0.335 End-of-day quote.112.90%
THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD. 0.00% 0.18 Delayed Quote.-23.40%
All news about CANNOVUM AG
09/08CANNOVUM : expands Supervisory Board and Medical Advisory Board
EQ
09/08PRESS RELEASE : Cannovum AG expands Supervisory Board and Medical Advisory Board
DJ
09/08Cannovum AG Has Appoints Priv. Doz. Dr. Med. Habil. Philipp Sewerin to the Supervisory ..
CI
09/06PRESS RELEASE : Cannovum AG starts European cannabis expansion with founding of Cannovum I..
DJ
09/06CANNOVUM : starts European cannabis expansion with founding of Cannovum Iberia LDA
EQ
09/06Cannovum AG Starts European Cannabis Expansion with Founding of Cannovum Iberia LDA
CI
06/29PRESS RELEASE : Cannovum AG enters the full-spectrum cannabis extract market
DJ
06/29CANNOVUM : enters the full-spectrum cannabis extract market
EQ
06/24PRESS RELEASE : Cannovum AG enters supply agreement for medical cannabis with Aurora Europ..
DJ
06/24CANNOVUM : enters supply agreement for medical cannabis with Aurora Europe
EQ
More news
Chart CANNOVUM AG
Duration : Period :
Cannovum AG Technical Analysis Chart | MarketScreener
Full-screen chart